Price:
Rs. 17,850.00
Sample Type: EDTA BLOOD
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What is the CLL Prognostication/Risk Stratification Gene Panel?
It is a genetic test at Metropolis Healthcare that analyzes multiple genes using NGS to assess prognosis and treatment response in CLL.
Who should consider this test?
Patients diagnosed with CLL or those under treatment may benefit to determine disease progression and guide therapy.
What sample is required for this test?
An EDTA blood sample is collected for DNA extraction and NGS analysis at Metropolis Healthcare.
Is fasting required for this test?
No fasting is necessary. The test can be performed without special preparation.
How accurate are the results from Metropolis Healthcare?
Metropolis ensures high accuracy using advanced NGS platforms, expert bioinformatics, and strict laboratory quality standards.
Can this test guide treatment decisions?
Yes, identifying pathogenic mutations helps clinicians choose personalized therapies, predict response, and monitor disease progression.
How long does it take to get the results?
Results are typically available within 2–3 weeks, depending on sample processing and sequencing at Metropolis Healthcare.
How does this test help in managing CLL?
It aids in risk stratification, therapy selection, and long-term monitoring to improve patient outcomes.